YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis

Zhengming Wu1, Junhui Su2, Fu-Long Li3

  • 1Department of Pharmacology and Moores Cancer Center, University of California, San Diego, La Jolla, CA, 92093, USA.

Nature Communications
|September 22, 2023
PubMed

Insights

Loss of YAP expression drives small cell lung cancer (SCLC) metastasis. Benzamide HDAC inhibitors restore YAP, suppressing SCLC spread and improving survival in mice.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metastasis

Background:

  • Small cell lung cancer (SCLC) is characterized by high lethality due to frequent metastasis.
  • Inactivating mutations in TP53 and RB1 are common in SCLC.
  • The molecular mechanisms driving SCLC metastasis remain incompletely understood.

Purpose of the Study:

  • To investigate the role of YAP expression in SCLC metastasis.
  • To elucidate the regulatory mechanisms of YAP transcription in SCLC.
  • To identify potential therapeutic strategies targeting SCLC metastasis.

Main Methods:

  • Analysis of YAP expression in SCLC cells.
  • Investigation of YAP target genes (CCN1/CCN2) and their role in migration.
  • Study of RB1 mutation, E2F7, and RCOR complex interaction with the YAP promoter.
  • Evaluation of benzamide family HDAC inhibitors in vitro and in a mouse model.

Main Results:

  • Loss of YAP expression correlates with increased ameboid migration and metastatic potential in SCLC.
  • YAP inhibits SCLC ameboid migration via CCN1/CCN2.
  • RB1 mutations lead to YAP transcriptional silencing through E2F7 and RCOR recruitment.
  • Benzamide HDAC inhibitors restore YAP expression by targeting the RCOR-HDAC complex, suppressing metastasis, and improving survival in mice.

Conclusions:

  • YAP plays a critical role in suppressing SCLC ameboid migration and metastasis.
  • The E2F7/RCOR/Sin3 HDAC complex mediates YAP transcriptional silencing in RB1-mutated SCLC.
  • Benzamide HDAC inhibitors represent a promising therapeutic strategy for SCLC by restoring YAP expression and inhibiting metastasis.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.4K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K